Market revenue in 2023 | USD 124.7 million |
Market revenue in 2030 | USD 203.5 million |
Growth rate | 7.2% (CAGR from 2023 to 2030) |
Largest segment | Outpatient facilities |
Fastest growing segment | Home Care |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Home Care, Research & Manufacturing |
Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, Illumina Inc, Roche Holding AG ADR, BD, Agilent Technologies Inc, Myriad Genetics Inc, Koninklijke Philips NV, Abbott Laboratories, Hitachi Ltd, Danaher Corp, Prestige Medical |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pancreatic cancer diagnostic market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 62.55% in 2023. Horizon Databook has segmented the India pancreatic cancer diagnostic market based on hospitals, outpatient facilities, home care, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
The prevalence of pancreatic cancer is rising in India, with an estimated surge in cases due to lifestyle changes, dietary habits, and genetic factors. The growing support from government funding agencies is one of the major factors expected to propel market growth. The Department of Biotechnology (DBT) plays an important role in managing and controlling cancer in India.
DBT is conducting multi-institutional networking & R&D programs and providing resources to individual investigators & institutions to conduct applied, basic, clinical, & translational research and develop novel techniques to prevent & treat diseases.
In October 2023, the Indian Institute of Technology, Madras, established a Center of Excellence to develop biomarkers for the early detection of pancreatic cancer. However, several advanced diagnostic tests remain expensive and may not be accessible to all population segments. While urban areas witness increased awareness and access to diagnostics, rural regions still lag significantly.
Horizon Databook provides a detailed overview of country-level data and insights on the India pancreatic cancer diagnostic market , including forecasts for subscribers. This country databook contains high-level insights into India pancreatic cancer diagnostic market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account